| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Feb 2, 2022Robotic prostatectomy performed by Doctor Alexandre Mottrie at Onze-Lieve-Vrouw Ziekenhuis (OLV) in Aalst, Belgium DUBLIN and AALST, Belgium, Feb. 2, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT),...
-
Jan 24, 2022Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration approval of its Intellis™ rechargeable neurostimulator and...
-
Jan 21, 2022- Multi-year partnerships to serve over 60,000 underserved and underrepresented K-12 students in Minnesota, Northern California and Puerto Rico
The Medtronic Foundation today announced 13 new partnerships with leading organizations serving underrepresented and underserved K-12 students in Minnesota, Northern California and Puerto Rico....
Jan 14, 2022DTM™ SCS endurance therapy enables long-lasting recharge-free performance on Vanta™ and 5-minute recharge on Intellis™ neurostimulators DUBLIN, Jan. 14, 2022 /PRNewswire/ -- Medtronic plc...
-
Jan 12, 2022
Sessions will include DTM™ SCS endurance therapy 3-month outcomes for patients with chronic back and leg pain DUBLIN, Jan. 12, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in...
-
Jan 10, 2022World's smallest pacemaker can now treat patients with AV block, bringing miniaturized, leadless pacing to more patients
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received approval from Japan's Ministry of Health, Labor and Welfare for the sale and reimbursement of...
-
Jan 10, 2022
First Medtronic TAVR system approved in China for patients with symptomatic severe aortic stenosis DUBLIN, Jan. 10, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare...
-
Jan 10, 2022
Acquisition to expand company's cardiac ablation portfolio, including first-time entry into mapping and navigation, within one of the fastest growing medtech markets DUBLIN, Jan. 10, 2022...
-
Jan 4, 2022
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate virtually in the 40th annual J.P. Morgan healthcare conference on Monday, January 10, 2022....
-
Dec 22, 2021Medicare coverage for Medtronic customers will be available 60 days after official publication
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) will expand Medicare coverage for all types of...
-
Dec 16, 2021Ivan Fong is named general counsel and secretary; Rick Kuntz, chief medical officer and chief scientific officer, announces his intent to retire
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, made two announcements today regarding its executive committee. Ivan Fong has been named as general counsel and secretary,...
-
Dec 15, 2021
Medtronic plc (NYSE:MDT) today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) on December 9 for the company's Northridge, California, facility, the...
Dec 14, 2021FDA clearance expands use of the INVOS™ 7100 system, helping clinicians better monitor organ-specific oxygen levels and identify warnings signs for neonates and children earlier DUBLIN, Dec. 14,...
-
Dec 13, 2021Study shows 57.1% of patients discontinued or reduced oral opioid prescription refills post-procedure and exhibited a decrease in payer costs¹
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the results of a study published in Osteoporosis International that demonstrate a decrease, and in some cases...
-
Dec 10, 2021
The board of directors of Medtronic plc (NYSE:MDT) on Thursday, December 9, 2021, approved the fiscal year 2022 third quarter cash dividend of $0.63 per ordinary share, representing a 9 percent...
Nov 23, 2021Company continued to launch new products, win share, and deliver strong earnings growth; market procedure volumes impacted by COVID-19 resurgenceMedtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2022, which ended October 29, 2021. Key Highlights Revenue of $7.8 billion increased 3% reported...
-
Nov 15, 2021Latest approval for PillCam™ further enables patients to receive gastrointestinal care in the comfort of their own home
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its PillCam™ Small Bowel 3...
Nov 15, 2021Four external appointments include new digital innovation leader, head of global strategy and two Operating Unit President roles within the Neuroscience Portfolio DUBLIN, Nov. 15, 2021...
-
Nov 15, 2021Strong ESG practices result in inclusion on the Dow Jones Sustainability World Index
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced its inclusion in the Dow Jones® Sustainability World Index (DJSI World) as one of the world's leading companies...
-
Nov 9, 2021
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2022 on Tuesday, November 23, 2021....
-
Nov 8, 2021
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced its ambition to achieve net zero carbon emissions by fiscal year (FY) 2045 across its operations and value chain...
-
Nov 6, 2021
Transfemoral access added into landmark APOLLO Pivotal Trial following IDE approval from FDA DUBLIN and ORLANDO, Fla., Nov. 6, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in...
-
Nov 5, 2021
TCT 2021: Intermediate risk TAVR patients demonstrate strong hemodynamics and stable valve performance at five years DUBLIN and ORLANDO, Fla., Nov. 5, 2021 /PRNewswire/ -- Medtronic plc...
-
Nov 4, 2021
New data from Medtronic Patient Preference study presented at TCT 2021; Medtronic adds to its clinical leadership for renal denervation with launch of the SPYRAL AFFIRM study DUBLIN and ORLANDO,...
-
Oct 21, 2021
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced Austin L. Chiang, M.D., M.P.H., assistant professor of medicine at Sidney Kimmel Medical College, chief medical...